NCT01135927View on ClinicalTrials.gov

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

insulin degludec

NN1250 (insulin degludec) injected s.c. (under the skin) once daily for 6 days

DRUG

insulin detemir

Insulin detemir injected s.c. (under the skin) once daily for 6 days

Trial Locations (1)

130-0004

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01135927 - A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter